Search

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

… Thursday, December 1, 2011 Summary Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain. In his January 1971 State of the Union address, President Richard Nixon officially declared a war on cancer, asking Congress

Students from Manhattan’s Urban Academy Laboratory School paid a visit to Marcel van den Brink’s lab at MSK.

… Friday, March 30, 2018 Summary A group of New York City high school students took a field trip to a lab at Memorial Sloan Kettering.  On Thursday, 16 students from the Urban Academy Laboratory School in Manhattan got a taste of what it’s like to do science in a modern cancer laboratory. Memorial Sloan

ATLANTA, June 5, 2006 - A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation. The results of the study, which are being presented today at the annual American Society of Clinical Oncology meeting, also provide the strongest evidence to date that this surgery significantly reduces the overall risk of BRCA-associated breast and ovarian cancers.

… Monday, June 5, 2006 A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women who carry a genetic mutation in the BRCA2 gene than for those who have a BRCA1 genetic mutation. The results of the study, which

Learn how a clinical trial for a new type of immunotherapy called TCR therapy benefited a patient with synovial sarcoma.

… Wednesday, July 16, 2025 It was hard enough the first time Conor Handley was diagnosed with cancer, at age 17. He had a rare soft tissue cancer called synovial sarcoma. Then three years after finishing treatment, early in his senior year of college, came the devastating news: His synovial sarcoma was

Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.

… Monday, July 18, 2022 Thirty-four-year-old Jason Mascolo put off getting the nagging pain in his leg checked out for years because he didn’t have health insurance. It wasn’t until he got a job with benefits — as a utility worker with Consolidated Edison — that he went to see a doctor. The news was not

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.

… Thursday, October 1, 2009 Summary Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer. Results from studies in cell cultures and mouse models suggest that the experimental

Dr. Tagore is a postdoctoral fellow in the Cancer Biology and Genetics Program at the Sloan Kettering Institute studying cell communication in cancer.

… Monday, June 8, 2020 Summary Mohita Tagore is a postdoctoral fellow in the Cancer Biology and Genetics Program at the Sloan Kettering Institute. She is a 2020 winner of a Kravis WISE postdoctoral fellowship and will be presenting her research at the inaugural Kravis WiSE Symposium on July 8, 2020. In

After immunotherapy and targeted therapy failed to bring a patient's melanoma under control, MSK doctors offered her a new treatment called tumor-infiltrating lymphocyte, or TIL, therapy.

… Tuesday, October 28, 2025 It was not the news that Pattie Fuller wanted to hear.  Doctors at a local hospital in upstate New York told her that despite surgery and several rounds of  immunotherapy , her  melanoma was growing. The melanoma ultimately grew to be stage 4. It spread from her scalp to the

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, September 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: MSK Receives National Cancer Institute (NCI) Specialized Programs of Research Excellence (SPORE) Grant Omar Abdel-Wahab and Martin Tallman The National Cancer Institute (NCI) awarded

Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantationoutcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease.

… Thursday, March 15, 2018 Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantation outcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease (GVHD). While